Thursday's Health Winners & Losers
Earnings were good to a few health companies, such as Immucor (BLUD), but not as nice to others on a gloomy Thursday in the market.
Immucor reported net income of $18.2 million, up 51% from $12.1 million for the same quarter last year. The company said it earned 26 cents a share. The Thomson Financial consensus target was 22 cents a share. The company gained $2.05, or 7.2%, to $30.63.
Also up, Affymetrix (AFFX) reported earnings after market close on Wednesday. The company said revenue rose 10% to $88.3 million, and it reported net income of $1.2 million, or 2 cents a share, compared with a loss of $10.1 million, or 15 cents a share, during the same period in 2006.
Looking ahead, Affymetrix is predicting revenue from $365 million to $385 million for fiscal 2007, and gross margins around 60%. Shares climbed $1.44, or 5.8%, to $26.30.But on the down side, Bristol-Myers Squibb (BMY) earned 37 cents a share, excluding one-time items, which is one penny better than the consensus of analysts polled by Thomson First Call. Revenue of $4.93 billion matched expectations. The company
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV